Dr Xiao-Qi Zhou and his team at the University of Bristol's Centre for Quantum Photonics in collaboration with the University of Queensland, Australia, have displayed that controlled operations, when the control bit exhibits state 1, can be simplified significantly on comparing with the standard technique.
By Dr. Cameron Chai
4 Aug 2011
Pharmaceutical researchers have achieved only 5% success in the clinical trials for anti-cancer drugs. In order to increase this success percentage, Japanese research team, headed by Dr. Tetsuya Terasaki has identified a new method to overcome the complications of producing effective drugs against diseases such as cancer.
By Dr. Cameron Chai
4 Aug 2011
A provider of logic non-volatile memory (LNVM) one-time programmable (OTP) memory IP cores for utilization in standard-logic CMOS processes, Sidense has declared that its SiPROM 1T-Fuse OTP macro products available at 130nm has passed the TSMC’s IP9000 assessment requirements.
By Dr. Cameron Chai
4 Aug 2011
Researchers from the Texas A&M University and the National Institute of Standards Technology (NIST) discovered unique carbon nanofiber-filled coatings that can replace the traditional fire-retardants employed in the polyurethane foam (PUF) utilized in upholstered mattresses and furniture.
For C-Suite, Technical, and Sales & Marketing managers, it's not too early to start planning for 2012. To lend a helping hand, The Microscopy & Imaging Place, Inc. ("The MIP") has just released thei...
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, is pleased to report on the research work from the Chemical Physics group of Professor Robert Magerle of the Chemnitz University of Technology.
MarketResearch.com has added a new electronics market report tilted Semiconductor Industry Market Analysis & Future Trends Worldwide (2010 - 2013) to its catalogue.
By Dr. Cameron Chai
3 Aug 2011
Researchers from University of Cincinnati (UC) have launched a disposable, economic lab-on-a-chip sensor to offer rapid feedback on the presence and levels of heavy metal particularly manganese in humans than existing technologies found in health-care centers.
By Dr. Cameron Chai
3 Aug 2011
Scientists from the Catalan Institute of Nanotechnology, ICREA, together with Universitat Autonoma de Barcelona, Pietro Gambardella, Kevin Garello, and Mihai Miron have collaborated with Gilles Gaudin and his colleagues at SPINTEC in Grenoble, France, have identified a new technique to write magnetic information on miniature magnetic bits, one after the other, rapidly with minimum consumption of energy.
By Dr. Cameron Chai
3 Aug 2011
Duke University’s electrical engineers have discovered a material that helps them in manipulating light resembling the way that electronics manipulates electron flow.
By Dr. Cameron Chai
3 Aug 2011
Rice University has developed graphene-based electrodes making flexible, transparent electronics possible in reality. The laboratory led by James Tour, Rice University chemist, has formed thin films that enhance LED lighting, solar panels, and touch-screen displays.
By Dr. Cameron Chai
3 Aug 2011
A provider of education and information resources to professionals globally, Elsevier Science & Technology Books has offered journals and books that speak about major nanotechnology breakthroughs.
Researchers at the Northwestern University have created a unique nanostructure that triggers a series of complex actions to promote the formation of new blood vessels, thereby contributing a therapy for situations that require increased flow of blood to supply the needed oxygen to the tissues.
By Dr. Cameron Chai
3 Aug 2011
Scientists at the ARC Centre of Excellence for Coherent X-ray Science (CXS) located at the University of Melbourne have developed a novel cold electron source that will increase the speed of nanoimaging for materials and drug development to a trillionth of a second as well as enhance its quality.
By Dr. Cameron Chai
3 Aug 2011
BioAlliance Pharma, a company developing specialty and orphan oncology products has declared the commencement of the production of clinical batches of Livatag, a regimen to supply doxorubicin in nanoparticle form to chemoresistant cells, for its phase III clinical trial for primary liver cancer.
By Dr. Cameron Chai
3 Aug 2011